ChromoGenics AB (publ) strengthens the board with Mari Broman and Peter Gustafson, both with a background in the real estate and finance industry. They were elected to the Board at the company's AGM on May 10, 2017.
"We welcome Mari and Peter to the Board. Now ChromoGenics is on the stock exchange and has begun the commercialization phase, which places new demands on the company. With Mari and Peter, expertise is being provided in both the real estate and finance industry, which will contribute positively to future conditions for growth and development, "says Anders Brännström, Chairman of the Board ChromoGenics.
Mari Broman has extensive experience in the construction and real estate industry and has had senior positions and board assignments in both the public sector and private industry.
"I look forward to contributing to the continued development of ChromoGenics. It is an exciting company with an interesting product right in the time when there is a high focus on sustainability and energy savings within the real estate industry, "says Mari Broman.
Peter Gustafson has long and wide experience in corporate finance, investment advice and business development in construction, property and infrastructure, as well as energy and energy technology.
"It will be exciting to take ChromoGenics to the next level in the growth phase. There is a great interest in ChromoGenics’ product and market analyzes show strong growth in the coming year. I look forward to being part of and contributing to the company's growth journey, "concludes Peter.
Thomas Almesjö, CEO
Susanne Andersson, CFO & Head of Communications
Tel: +46 18 430 0430
ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.